A RANDOMISED, OPEN-LABEL CLINICAL TRIAL TO ASSESS CERTAIN METABOLIC SIDE EFFECTS OF NOVEL ATYPICAL ANTIPSYCHOTICS - BLONANSERIN IN COMPARISON WITH AMISULPRIDE,IN PERSONS WITH PSYCHOSIS.

Trial Profile

A RANDOMISED, OPEN-LABEL CLINICAL TRIAL TO ASSESS CERTAIN METABOLIC SIDE EFFECTS OF NOVEL ATYPICAL ANTIPSYCHOTICS - BLONANSERIN IN COMPARISON WITH AMISULPRIDE,IN PERSONS WITH PSYCHOSIS.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 30 Aug 2016

At a glance

  • Drugs Blonanserin (Primary) ; Amisulpride
  • Indications Psychotic disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 25 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top